Approval of the tenth ticker of the corona


The World Health Organization (WHO) has approved the 10th vaccine against the deadly corona virus called novaxovid. Which was earlier approved by the European Medicines Agency (EMA) after evaluation. This vaccine was also developed by NovaVax and CEPI (Coalition for the Epidemic Preparedness Innovations).

The approval was given on Tuesday (December 21). The vaccine was approved by the European Union before the World Health Organization. The fifth vaccine to be approved by the EU is Novaxovid.

On December 16, Hua approved NovaVax for emergency use. In this regard, Hu said, ‘NovaVax and Novaxovid are vaccines produced using the same technology. The two vaccines can be stored in the refrigerator at a temperature of 2 C to 6

Regarding Novaxovid, the EMA said, “It is a protein-based vaccine and it has already been approved. The vaccine will be able to support the immunization programs of EU member states. Especially in the difficult times of Corona. ‘

This vaccine prepares the human body in such a way that it can fight against corona and defeat it. That is, it works against corona by strengthening the immune system. The vaccine also uses a protein that is coronary spike on the surface of the protein, made in the laboratory.